Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication

Table 1 Inhibition rate of suberoylanilide hydroxamic acid on HepG2.2.15 cells

SAHA (μmol/L)	24 h	48 h	72 h
2.5	8% ± 0.54%	15% ± 1.52%	23% ± 1.39%
5.0	13% ± 0.63%	22% ± 1.68%	34% ± 1.61%
7.5	28% ± 1.56%	39% ± 1.67%	50% ± 1.70%
10.0	42% ± 1.72%	51% ± 1.82%	66% ± 1.76%

P < 0.05 for comparison among different concentration and different treatment time, respectively. SAHA: Suberoylanilide hydroxamic acid.